Key terms

About ASLN

Aslan Pharmaceuticals Ltd. is a clinical-stage immunology biopharmaceutical company, which develops novel therapeutics. It focuses on atopic dermatitis, other immunology indications and autoimmune disease. Its pipeline includes ASLAN003 and Eblasakimab. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale, and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ASLN news

Apr 15 6:20am ET Analysts Offer Insights on Healthcare Companies: Aslan Pharmaceuticals (ASLN), Rewalk Robotics (LFWD) and Apellis Pharmaceuticals (APLS) by TipRanks Apr 12 9:28am ET Aslan Pharmaceuticals Launches $12M ADS Offering by TipRanks Apr 12 8:02am ET Aslan Pharmaceuticals reports Q4 EPS (3c) vs (4c) last year by TipRanks Apr 12 6:57am ET ASLAN Pharmaceuticals Advances Clinical Trials by TipRanks Mar 25 4:48pm ET Aslan Pharmaceuticals files to sell 125M ordinary shares for holders by TipRanks Mar 18 6:30am ET Analysts Offer Insights on Healthcare Companies: Aslan Pharmaceuticals (ASLN), Urogen Pharma (URGN) and Legend Biotech (LEGN) by TipRanks Mar 18 6:13am ET Aslan Pharmaceuticals price target lowered to $9 from $17 at H.C. Wainwright by TipRanks Mar 15 11:32am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 14 11:01am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 13 11:07am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 13 7:00am ET Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Legend Biotech (LEGN) and Aslan Pharmaceuticals (ASLN) by TipRanks Mar 13 6:50am ET Aslan Pharmaceuticals price target lowered to $10 from $15 at Piper Sandler by TipRanks Mar 12 2:37pm ET Aslan Pharmaceuticals announces $5M registered direct offering by TipRanks Mar 11 2:45pm ET Piper ‘confident’ partner or buyer will see benefit of Aslan’s eblasakimab by TipRanks Mar 11 7:14am ET Aslan Pharmaceuticals provides TREK-DX study update by TipRanks Mar 06 7:11am ET Aslan Pharmaceuticals announces new data on eblasakimab, appointments by TipRanks Feb 29 7:20am ET Aslan Pharmaceuticals receives favorable opintion from EPO on farudodstat by TipRanks

No recent press releases are available for ASLN

ASLN Financials

1-year income & revenue

Key terms

ASLN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ASLN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days